Medical Devices Investors & VC Firms in United States
1104 firms in this list, with a median first check of $500K. 275 of them lead rounds. Generated from verified public data and updated continuously.
Protocol Labs
San FranciscoPre-Seed–Series A
4 people
New Rhein Healthcare Investors, LLC
PhiladelphiaSeries B–Late Stage
15 people
6 Dimensions Capital
Grand CaymanSeed–Late Stage
17 people
Jumpstart Foundry
NashvillePre-Seed–Seed
5 people
Kaleida Capital
San Diego
14 people
53 Stations
ChicagoPre-Seed–Series A
12 people
American Century Private Investments
Kansas CityGrowth
18 people
Range VC
DenverPre-Seed–Seed$1M – $3M
3 people
Scion Life Sciences
New YorkSeed–Late Stage$1K – $60M
12 people
Propel Bio Partners
Los AngelesSeed–Series A
17 people
Riverfront Ventures, LLC
PittsburghSeed–Series A$250K – $1M
8 people
ISA Ventures
Cedar RapidsPre-Seed–Late Stage$25K – $1M
4 people
Abell Foundation, Inc.
BaltimoreSeed–Growth$150K – $500K
Bootstrap Venture Partners
Solana BeachSeed–Series A
6 people
Novalis LifeSciences
PortsmouthSeed–Late Stage
9 people
Plains Ventures
Oklahoma CitySeed–Series A$250K – $1M
3 people
Prana Tech Ventures
MetuchenPre-Seed–Seed
12 people
BioStar Ventures
PetoskeyGrowth
14 people
Catalyst Health Ventures
BostonSeed–Series A$1M – $3M
7 people
Easton Capital
New YorkSeed–Series B$10M – $20M
7 people
Virginia Venture Partners
RichmondPre-Seed–Seed$100K
10 people
Claremont Creek Ventures
OaklandPre-Seed–Series A$500K – $3M
6 people
Coddle Creek Capital
KannapolisPre-Seed–Seed$150K – $650K
15 people
Costella Kirsch
Menlo ParkSeed–Growth
6 people
Related lists
Investors & VC Firms in North America (13286)Investors & VC Firms in United States (12284)Investors & VC Firms in Europe (6052)AI & Machine Learning Investors & VC Firms (5303)Investors & VC Firms in Global (5278)Fintech Investors & VC Firms (5112)Healthtech Investors & VC Firms (4639)SaaS Investors & VC Firms (4498)Enterprise Software Investors & VC Firms (4394)Crypto & Web3 Investors & VC Firms (4130)
Data sourced from public filings and firms' own websites — see our methodology.





























































































